2,500
Participants
Start Date
March 16, 2020
Primary Completion Date
January 1, 2026
Study Completion Date
January 31, 2026
Membrane-based immunoassay kit
The kit is a qualitative membrane-based immunoassay to detect IgG and IgM antibodies to SARS-CoV-2 in whole blood, serum or plasma specimens. IgG and IgM detection components are separate allowing for differential detection of each antibody.
Quantitative antibody Tests
Antibody titres will be measured from whole blood samples taken from volunteers.
PCR Test
PCR tests will be conducted on throat swabs taken from volunteers.
RECRUITING
Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge, London
Richmond Pharmacology Limited
INDUSTRY
Richmond Research Institute
INDUSTRY